Assessing the population at risk of Zika virus in Asia - Is the emergency really over?

BMJ Global Health

Volumn 2, Issue 3, 2017, Pages

  Siraj, Amir S ^a   Perkins, T Alex ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056438061     PISSN: None     EISSN: 20597908     Source Type: Journal    
DOI: 10.1136/bmjgh-2017-000309     Document Type: Article

References (51)

1. World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly. other neurological disorders and Zika virus. 2016 http://www.who. int/mediacentre/news/statements/2016/zikafifth-ec/en/ (accessed 24 Nov 2016).
2. World Health Organization. Zika risk assessment in the Western Pacific Region . 2016 http://www.wpro. who. int/outbreaks_emergencies/zika/WPR_Zika_RiskAssessment/en/.
3. Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013;496:504-7.
4. Posen HJ, Keystone JS, Gubbay JB, et al. Epidemiology of Zika virus, 1947-2007. BMJ Glob Health 2016;1:e000087.
5. Lessler J, Chaisson LH, Kucirka LM, et al. Assessing the global threat from Zika virus. Science 2016;353:aaf8160.
6. Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus serocross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016;17:1102-8.
7. Priyamvada L, Quicke KM, Hudson WH, et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 2016;113:7852-7.
8. Bardina SV, Bunduc P, Tripathi S, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 2017;356:175-80.
9. Durbin AP. Dengue Antibody and Zika: Friend or Foe? Trends Immunol 2016;37:635-6.
10. Rabaa MA, Klungthong C, Yoon IK, et al. Frequent in-migration and highly focal transmission of dengue viruses among children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis 2013;7:e1990.
11. Salje H, Cauchemez S, Alera MT, et al. Reconstruction of 60 years of chikungunya epidemiology in the Philippines demonstrates episodic and focal transmission. J Infect Dis 2016;213:604-10.
12. Riley S. Making high-res Zika maps. Nat Microbiol 2016;1:16157.
13. Bogoch II, Brady OJ, Kraemer MU, et al. Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: a modelling study. Lancet Infect Dis 2016;16:1237-45.
14. Keeling M, Rohani P. Modeling infectious diseases in humans and animals. Princeton University Press: Princeton, 2007.
15. Lai S, Huang Z, Zhou H, et al. The changing epidemiology of dengue in China, 1990-2014: a descriptive analysis of 25 years of nationwide surveillance data. BMC Med 2015;13:100.
16. Perkins TA, Siraj AS, Ruktanonchai CW, et al. Model-based projections of Zika virus infections in childbearing women in the Americas. Nat Microbiol 2016;1:16126.
17. Petersen LR, Jamieson DJ, Powers AM, et al. Zika virus. N Engl J Med 2016;374:1552-63.
18. Pompon J, Morales-Vargas R, Manuel M, et al. A Zika virus from America is more efficiently transmitted than an Asian virus by Aedes aegypti mosquitoes from Asia. Sci Rep 2017;7:1215.
19. WorldPop. Population - individual countries. 2016 http://www.worldpop. org. uk/data/data_sources/ (accessed 24 Nov 2016).
20. UNPD. World Population Prospects: the 2015 Revision, DVD edition 2015. New York: Department of Economic and Social AffairsUnited Nations, 2015.
21. Hijmans RJ, Cameron SE, Parra JL, et al. Very high resolution interpolated climate surfaces for global land areas. Int J Climatol 2005;25:1965-78.
22. Brady OJ, Johansson MA, Guerra CA, et al. Modelling adult Aedes aegypti and Aedes albopictus survival at different temperatures in laboratory and field settings. Parasit Vectors 2013;6:351-12.
23. Chan M, Johansson MA. The incubation periods of dengue viruses. PLoS One 2012;7:e50972.
24. Kraemer MU, Sinka ME, Duda KA, et al. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife 2015;4:08347.
25. Reiter P, Lathrop S, Bunning M, et al. Texas lifestyle limits transmission of dengue virus. Emerg Infect Dis 2003;9:86-9.
26. Nordhaus WD. Geography and macroeconomics: new data and new findings. Proc Natl Acad Sci U S A 2006;103:3510-7.
27. The World Factbook (US Central Intelligence Agency). 2016 https://www.cia. gov/library/publications/the-world-factbook/geos/xx. html (accessed 25 Nov 2016).
28. Smith DL, Battle KE, Hay SI, et al. Ross, Macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens. PLoS Pathog 2012;8:e1002588.
29. Christofferson RC, Emergence ZV. Zika virus emergence and expansion: lessons learned from dengue and chikungunya may not provide all the answers. Am J Trop Med Hyg 2016;95:15-18.
30. Sergon K, Njuguna C, Kalani R, et al. Seroprevalence of chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am J Trop Med Hyg;2008:333-7.
31. Schwarz NG, Girmann M, Randriamampionona N, et al. Seroprevalence of antibodies against chikungunya, dengue, and Rift Valley fever viruses after febrile illness outbreak, Madagascar. Emerg Infect Dis 2012;18:1780-6.
32. Sissoko D, Malvy D, Giry C, et al. Outbreak of chikungunya fever in Mayotte, Comoros Archipelago, 2005-2006. Trans R Soc Trop Med Hyg 2008;102:780-6.
33. Dwibedi B, Sabat J, Mahapatra N, et al. Rapid spread of chikungunya virus infection in Orissa: India. Indian J Med Res 2011;133:316-21.
34. Gay N, Rousset D, Huc P, et al. Seroprevalence and asymptomatic rates of Asian lineage chikungunya virus infection on Saint Martin, Caribbean. Am J Trop Med Hyg 2015;94:393-6.
35. Moro ML, Gagliotti C, Silvi G, et al. Chikungunya virus in northeastern Italy: a seroprevalence survey. Am J Trop Med Hyg 2010;82:508-11.
36. Balmaseda A, Gordon A, Gresh L, et al. Clinical attack rate of chikungunya in a cohort of Nicaraguan children. Am J Trop Med Hyg 2016;94:397-9.
37. Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med 2009;360:2536-43.
38. Basarab M, Bowman C, Aarons EJ, et al. Zika virus. BMJ 2016;352:i1049.
39. Cunha RV, Trinta KS, Montalbano CA, et al. Seroprevalence of chikungunya virus in a rural community in Brazil. PLoS Negl Trop Dis 2017;11:e0005319.
40. de Araújo TV, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis 2016;16:1356-63.
41. Simmons G, Brès V, Lu K, et al. High incidence of chikungunya virus and frequency of viremic blood donations during Epidemic, Puerto Rico, USA, 2014. Emerg Infect Dis 2016;22:1221-8.
42. Zambrano H, Waggoner J, León K, et al. High incidence of Zika virus infection detected in plasma and cervical cytology specimens from pregnant women in Guayaquil, Ecuador. Am J Reprod Immunol 2017;77:e12630.
43. Hobbs NT, Hooten MB. Bayesian models: a statistical primer for ecologists. Princeton University Press: Princeton, 2015.
44. Duong V, Dussart P, Buchy P. Zika virus in Asia. Int J Infect Dis 2017;54:121-8.
45. Bogoch II, Brady OJ, Kraemer MU, et al. Anticipating the international spread of Zika virus from Brazil. Lancet 2016;387:335-6.
46. Caminade C, Turner J, Metelmann S, et al. Global risk model for vector-borne transmission of Zika virus reveals the role of El Niño 2015. Proc Natl Acad Sci U S A 2017;114:119-24.
47. Wikan N, Smith DR. Zika virus from a Southeast Asian perspective. Asian Pac J Trop Med 2017;10:1-5.
48. World Health Organization. Zika virus infection - India. Emergency Preparedness, Response. Emergency outbreak news. 2017 http://who. int/csr/don/26- may- 2017- zika-ind/en/ (accessed 27 May 2017).
49. Perkins TA. Retracing Zika's footsteps across the Americas with computational modeling. Proc Natl Acad Sci U S A 2017;114:5558-60.
50. Dhillon RS, Srikrishna D, Jha AK. Containing Zika while we wait for a vaccine. BMJ 2017;356:j379.
51. Metcalf CJ, Farrar J, Cutts FT, et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet 2016;388:728-30.